Under these circumstances, the diagnosis of a NSCLC NOS is justifiably accompanied by diagnostic uncertainty, and the pathologist should in this case be alerted of the possibility of trying to recruit clinical information or using a more extensive panel (for example, including CK5 for the case of p40 negative SCC or other transcription factors to exclude metastasis). This evidence concerns the gene KRT5 and non-small cell lung carcinoma.